Chemical Component Summary

Name(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
Identifiers2-(5,6-dimethyl-9-oxidanylidene-xanthen-4-yl)ethanoic acid
FormulaC17 H14 O4
Molecular Weight282.29
TypeNON-POLYMER
Isomeric SMILESCc1ccc2C(=O)c3cccc(CC(O)=O)c3Oc2c1C
InChIInChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)
InChIKeyXGOYIMQSIKSOBS-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count35
Chiral Atom Count0
Bond Count37
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB06235 
NameVadimezan
Groupsinvestigational
Synonyms
  • 5,6-Dimethylxanthenoneacetic acid
  • DMXAA
  • Vadimezan sodium
  • Vadim√©zan
  • Vadimezan
IndicationInvestigated for use/treatment in solid tumors, lung cancer, ovarian cancer, and prostate cancer.
Categories
  • Antineoplastic Agents
  • Cytochrome P-450 CYP1A2 Substrates
  • Cytochrome P-450 Substrates
  • Heterocyclic Compounds, Fused-Ring
  • UGT1A9 Substrates
CAS number117570-53-3

Drug Targets

NameTarget SequencePharmacological ActionActions
UDP-glucuronosyltransferase 1-9MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL...unknownsubstrate
UDP-glucuronosyltransferase 2B7MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRG...unknownsubstrate
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682